CAS 2227149-22-4
:DS18561882
Description:
As of my last update in October 2023, specific information about the chemical substance identified as "DS18561882" with the CAS number "2227149-22-4" is not widely available in public databases or literature. This may indicate that it is a novel compound, a proprietary substance, or one that has not yet been extensively studied or characterized in the scientific community. Generally, chemical substances can be characterized by their molecular formula, structure, physical properties (such as melting point, boiling point, and solubility), and chemical behavior (including reactivity and stability). For detailed characteristics, including safety data, synthesis methods, and applications, it is advisable to consult specialized chemical databases, scientific publications, or the manufacturer's documentation if available. If you have access to specific databases or resources, they may provide more comprehensive insights into this particular compound.
Formula:C28H31F3N4O6S
Synonyms:- Methanesulfonamide, N-[4-[[8-[(3S)-3,4-dimethyl-1-piperazinyl]-1,5-dihydro-7-methyl-5-oxo-2H-[1]benzopyrano[3,4-c]pyridin-3(4H)-yl]carbonyl]-2-(trifluoromethoxy)phenyl]-
- DS18561882
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
DS18561882
CAS:DS18561882 is a mitochondria-targeting drug that can induce apoptotic cell death. It has been shown to be clinically relevant in phase II clinical studies. DS18561882 may be used as a prognostic marker for cancer patients, and it suppresses the expression of genes that promote cell proliferation. This drug also inhibits protein synthesis, which causes apoptosis by targeting the mitochondria. DS18561882 is orally active and can be used as an anticancer agent against solid tumors.Formula:C28H31F3N4O6SPurity:Min. 95%Molecular weight:608.6 g/molDS18561882
CAS:DS18561882: Potent MTHFD2 inhibitor (IC50=0.0063), inhibits MTHFD1 (IC50=0.57), good oral kinetics.Formula:C28H31F3N4O6SPurity:98.19% - >99.99%Color and Shape:SolidMolecular weight:608.63
